Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 1
1984 2
1988 1
1991 3
1992 2
1993 1
1995 1
1996 1
1997 1
1998 2
2000 3
2001 1
2002 5
2003 7
2004 6
2005 5
2006 1
2007 3
2008 3
2009 5
2010 4
2011 3
2012 1
2013 5
2015 1
2016 2
2017 4
2018 2
2019 4
2020 5
2021 5
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Benign adrenal gland pheochromocytoma"
Page 1
Malignant pheochromocytoma and paraganglioma: management options.
Corssmit EPM, Snel M, Kapiteijn E. Corssmit EPM, et al. Curr Opin Oncol. 2020 Jan;32(1):20-26. doi: 10.1097/CCO.0000000000000589. Curr Opin Oncol. 2020. PMID: 31599769 Review.
PURPOSE OF REVIEW: Although the majority of pheochromocytoma and paraganglioma are benign, 15-17% develop metastatic disease, being present at the initial diagnosis in about 11-31% of cases. ...For individual patients, overall survival, progression-free survival, an …
PURPOSE OF REVIEW: Although the majority of pheochromocytoma and paraganglioma are benign, 15-17% develop metastatic disease, …
Robot-assisted adrenalectomy: indications and drawbacks.
Nomine-Criqui C, Germain A, Ayav A, Bresler L, Brunaud L. Nomine-Criqui C, et al. Updates Surg. 2017 Jun;69(2):127-133. doi: 10.1007/s13304-017-0448-6. Epub 2017 May 12. Updates Surg. 2017. PMID: 28497219 Review.
Adrenal tumors can vary from a benign adrenocortical adenoma with no hormonal secretion to a secretory adrenocortical malignancy (adrenocortical carcinoma) or a hormone-secreting tumor of the adrenal medulla (pheochromocytoma). Currently, laparoscopic …
Adrenal tumors can vary from a benign adrenocortical adenoma with no hormonal secretion to a secretory adrenocortical malignan …
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
Ilanchezhian M, Jha A, Pacak K, Del Rivero J. Ilanchezhian M, et al. Curr Treat Options Oncol. 2020 Aug 29;21(11):85. doi: 10.1007/s11864-020-00787-z. Curr Treat Options Oncol. 2020. PMID: 32862332 Free PMC article. Review.
The incidence of metastatic pheochromocytoma (PHEO) and paraganglioma (PGL) may occur in as many as 35% of patients particularly with PGL and even more frequently in those with specific mutations. Biochemical, morphological, and molecular markers have been investigated for …
The incidence of metastatic pheochromocytoma (PHEO) and paraganglioma (PGL) may occur in as many as 35% of patients particularly with …
Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World.
Patel M, Tena I, Jha A, Taieb D, Pacak K. Patel M, et al. Front Endocrinol (Lausanne). 2021 Mar 29;12:625312. doi: 10.3389/fendo.2021.625312. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33854479 Free PMC article. Review.
Radioisotope-labeled somatostatin analogs are utilized for both tumor localization and peptide radionuclide therapy, with (68)Ga-DOTATATE and (177)Lu-DOTATATE respectively. Benign and malignant pheochromocytomas and paragangliomas also overexpress somatostatin recep …
Radioisotope-labeled somatostatin analogs are utilized for both tumor localization and peptide radionuclide therapy, with (68)Ga-DOTATATE an …
Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia.
El-Maouche D, Hannah-Shmouni F, Mallappa A, Hargreaves CJ, Avila NA, Merke DP. El-Maouche D, et al. Clin Endocrinol (Oxf). 2019 Aug;91(2):247-255. doi: 10.1111/cen.13996. Epub 2019 May 7. Clin Endocrinol (Oxf). 2019. PMID: 31001843 Free PMC article. Clinical Trial.
OBJECTIVE: Adrenonodular hyperplasia and tumour formation are potential long-term complications of congenital adrenal hyperplasia (CAH) with little known regarding the clinical implications. ...RESULTS: Over one-third of the cohort was obese. 53% had elevated 17-OH- …
OBJECTIVE: Adrenonodular hyperplasia and tumour formation are potential long-term complications of congenital adrenal hyperplasia (CA …
Percutaneous ablation of adrenal tumors.
Venkatesan AM, Locklin J, Dupuy DE, Wood BJ. Venkatesan AM, et al. Tech Vasc Interv Radiol. 2010 Jun;13(2):89-99. doi: 10.1053/j.tvir.2010.02.004. Tech Vasc Interv Radiol. 2010. PMID: 20540918 Free PMC article. Review.
Adrenal tumors comprise a broad spectrum of benign and malignant neoplasms and include functional adrenal adenomas, pheochromocytomas, primary adrenocortical carcinoma, and adrenal metastases. ...Local tumor ablation in the adrenal gla …
Adrenal tumors comprise a broad spectrum of benign and malignant neoplasms and include functional adrenal adenomas, …
Contemporary imaging of incidentally discovered adrenal masses.
Wale DJ, Wong KK, Viglianti BL, Rubello D, Gross MD. Wale DJ, et al. Biomed Pharmacother. 2017 Mar;87:256-262. doi: 10.1016/j.biopha.2016.12.090. Epub 2017 Jan 4. Biomed Pharmacother. 2017. PMID: 28063406 Review.
Adrenal lesions are routinely encountered incidentally in clinical practice. Although most of these lesions are benign, malignancy needs to be excluded. Therefore, the initial clinical workup is to exclude aggressive characteristics suggesting malignan …
Adrenal lesions are routinely encountered incidentally in clinical practice. Although most of these lesions are benign, …
Thermal ablation in adrenal disorders: a discussion of the technology, the clinical evidence and the future.
Donlon P, Dennedy MC. Donlon P, et al. Curr Opin Endocrinol Diabetes Obes. 2021 Jun 1;28(3):291-302. doi: 10.1097/MED.0000000000000627. Curr Opin Endocrinol Diabetes Obes. 2021. PMID: 33741778 Free PMC article. Review.
PURPOSE OF REVIEW: To summarise the emerging role of thermal ablation as a therapeutic modality in the management of functioning adrenal tumours and metastases to the adrenal gland. RECENT FINDINGS: Observational evidence has demonstrated the benefit of therm …
PURPOSE OF REVIEW: To summarise the emerging role of thermal ablation as a therapeutic modality in the management of functioning adrenal …
Factors associated with postoperative complications and costs for adrenalectomy in benign adrenal disorders.
Sung TY, Tennakoon L, Alobuia WM, Seib C, Cisco R, Lin D, Kebebew E. Sung TY, et al. Surgery. 2022 Jun;171(6):1519-1525. doi: 10.1016/j.surg.2021.10.065. Epub 2021 Nov 29. Surgery. 2022. PMID: 34857386
METHODS: The 2016 National Inpatient Sample data were used to identify patients who underwent adrenalectomy for benign adrenal disorders, such as Cushing syndrome, primary hyperaldosteronism, pheochromocytoma, and other benign neoplasms defined using t …
METHODS: The 2016 National Inpatient Sample data were used to identify patients who underwent adrenalectomy for benign adrenal …
Discrepancies in the Recommended Management of Adrenal Incidentalomas by Various Guidelines.
Maas M, Nassiri N, Bhanvadia S, Carmichael JD, Duddalwar V, Daneshmand S. Maas M, et al. J Urol. 2021 Jan;205(1):52-59. doi: 10.1097/JU.0000000000001342. Epub 2020 Aug 28. J Urol. 2021. PMID: 32856984
RESULTS: There is little debate among the reviewed guidelines as to the initial evaluation of an adrenal incidentaloma. All patients with a newly discovered adrenal incidentaloma should receive an unenhanced computerized tomogram and hormone screen. The most signifi …
RESULTS: There is little debate among the reviewed guidelines as to the initial evaluation of an adrenal incidentaloma. All patients …
87 results